ரிபேரா தீர்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) is moving ahead with advancing its efforts with Ribera Solutions Conect2Med platform with Oncology Pharma s exclusivity for oncology, including drug development, clinical trials, personalized oncology and therapeutics. Ribera has been developing its platform and Oncology Pharma, under its License Agreement, is preparing the necessary steps to proceed to advance the development and implementation. Connect2Med is a patient engagement and retention platform designed to improve the clinical trial experience for both patients and providers. With Connect2Med, sponsors, CROs, and sites have a place for leads, or people in their databases, to live in an online community. The platform provides a private, secure space where people interested in or recruited to clinical trials have a safe, closed community they can join that provides trustworthy information and

United statesSan franciscoKostenloser wertpapierhandelRibera solutionsOncology pharma incOncology pharmaRibera solution conectLicense agreementAdvisory boardSansome streetஒன்றுபட்டது மாநிலங்களில்சான் பிரான்சிஸ்கோரிபேரா தீர்வுகள்புற்றுநோயியல் பார்மா இன்க்புற்றுநோயியல் பார்மா